or Try an Advanced Search...

    Technical Analysis for PCSA - Processa Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    C 2.09 -6.70% -0.15
    PCSA closed down 6.7 percent on Monday, July 1, 2024, on 1 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical PCSA trend table...
    Date Alert Name Type % Chg
    Bearish Engulfing Bearish 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Pocket Pivot Bullish Swing Setup -6.70%
    Upper Bollinger Band Walk Strength -6.70%
    Wide Bands Range Expansion -6.70%
    Above Upper BB Strength -6.70%
    Overbought Stochastic Strength -6.70%
    Older End-of-Day Signals for PCSA ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 9 hours ago
    Down 2 % about 9 hours ago
    Down 1% about 9 hours ago
    Fell Below Upper Bollinger Band about 9 hours ago
    60 Minute Opening Range Breakout 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    PCSA Chart by TradingView
    Basic chart:

    Profile

    Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its product pipeline is PCS499, which is use for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on October 2, 2017 and is headquartered in Hanover, MD.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Drug Products

    Is PCSA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer
    May 6 Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
    Apr 30 Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research
    Apr 26 Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Apr 25 Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Apr 25 POET, PCSA and BRFH are among premarket gainers
    Apr 11 Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial
    Apr 7 Insider Buyers At Processa Pharmaceuticals Recover Some Losses, But Still Down US$40k
    Mar 28 Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
    Mar 25 Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting
    See more PCSA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 18.0
    52 Week Low 1.4
    Average Volume 1,695,127
    200-Day Moving Average 4.77
    50-Day Moving Average 1.93
    20-Day Moving Average 1.84
    10-Day Moving Average 2.00
    Average True Range 0.18
    RSI (14) 57.26
    ADX 19.41
    +DI 32.17
    -DI 14.47
    Chandelier Exit (Long, 3 ATRs) 1.87
    Chandelier Exit (Short, 3 ATRs) 1.95
    Upper Bollinger Bands 2.22
    Lower Bollinger Band 1.46
    Percent B (%b) 0.83
    BandWidth 41.49
    MACD Line 0.07
    MACD Signal Line 0.01
    MACD Histogram 0.055
    Fundamentals Value
    Market Cap 3.57 Million
    Num Shares 1.71 Million
    EPS -22.80
    Price-to-Earnings (P/E) Ratio -0.09
    Price-to-Sales 0.00
    Price-to-Book 0.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.33
    Resistance 3 (R3) 2.35 2.30 2.29
    Resistance 2 (R2) 2.30 2.24 2.29 2.28
    Resistance 1 (R1) 2.19 2.20 2.17 2.17 2.26
    Pivot Point 2.14 2.14 2.12 2.13 2.14
    Support 1 (S1) 2.03 2.08 2.01 2.01 1.92
    Support 2 (S2) 1.98 2.04 1.97 1.90
    Support 3 (S3) 1.87 1.98 1.89
    Support 4 (S4) 1.85